The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

We use cookies to improve your experience and serve personalized ads.

By clicking Accept, you consent to our use of advertising cookies. See our Privacy Policy for details.

StocksMedium•7 April 2026•

1 min read

22nd Century Group Expands Reduced Nicotine Line to Target $82 Billion US Market

Key Facts

122nd Century Group is advancing a 100mm version of its VLN® reduced nicotine cigarette to target the $82 billion U.S. cigarette market.

2The company holds the only FDA authorization for low nicotine combustible cigarettes.

3The 100mm cigarette segment represents approximately half of the U.S. cigarette market.

Create Free Account

22nd Century Group (Nasdaq: XXII) is advancing the development of a 100mm version of its VLN® reduced nicotine cigarettes to capture a larger share of the $82 billion U.S. cigarette market. The 100mm segment represents approximately half of the U.S. market, making this expansion a strategic move to address wider consumer preferences. As the only company holding FDA authorization for low nicotine combustible cigarettes, this development leverages a significant regulatory advantage. The company is also pursuing additional PMTA submissions to further increase its retail penetration and market presence. This expansion is expected to unlock new growth opportunities and potential licensing deals. Analysts view this move as a bullish signal for the company's long-term revenue potential and market positioning.